Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ningning Liu

Showing results (271-280 of 285) with videos related to

Pageof 29
Sort By:
Cell Research|September 1, 2010
Physiological levels of ATP negatively regulate proteasome functionHongbiao Huang, Xiaoyan Zhang, Shujue Li, et al.
Nature Communications|March 7, 2020
Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formationQing Ji, Lihong Zhou, Hua Sui, et al.
Nature Communications|November 19, 2021
Inflammasome-mediated GSDMD activation facilitates escape of Candida albicans from macrophagesXionghui Ding, Hiroto Kambara, Rongxia Guo, et al.
Scientific Reports|June 11, 2014
A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidasesNingning Liu, Chunjiao Liu, Xiaofen Li, et al.
Cell Death & Disease|June 16, 2017
Bilirubin neurotoxicity is associated with proteasome inhibitionHongbiao Huang, Mingxing Guo, Ningning Liu, et al.
Scientific Reports|April 27, 2016
MYH9 is an Essential Factor for Porcine Reproductive and Respiratory Syndrome Virus InfectionJiming Gao, Shuqi Xiao, Yihong Xiao, et al.
Blood|January 22, 2025
CD44-mediated metabolic rewiring is a targetable dependency of IDH-mutant leukemiaJunhua Lyu, Yuxuan Liu, Ningning Liu, et al.
Frontiers in Bioscience (Elite Edition)|May 31, 2011
Sanggenon C decreases tumor cell viability associated with proteasome inhibitionHongbiao Huang, Ningning Liu, Kai Zhao, et al.
Science Bulletin|January 19, 2023
Anisotropic gapping of topological Weyl rings in the charge-density-wave superconductor In<sub>x</sub>TaSe<sub>2</sub>Yupeng Li, Yi Wu, Chenchao Xu, et al.
Oncotarget|July 1, 2014
Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growthNingning Liu, Xiaofen Li, Hongbiao Huang, et al.
Pageof 29

Showing results (271-280 of 285) with videos related to

Sort By:
Pageof 29
Cell Research|September 1, 2010
Physiological levels of ATP negatively regulate proteasome functionHongbiao Huang, Xiaoyan Zhang, Shujue Li, et al.
Nature Communications|March 7, 2020
Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formationQing Ji, Lihong Zhou, Hua Sui, et al.
Nature Communications|November 19, 2021
Inflammasome-mediated GSDMD activation facilitates escape of Candida albicans from macrophagesXionghui Ding, Hiroto Kambara, Rongxia Guo, et al.
Scientific Reports|June 11, 2014
A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidasesNingning Liu, Chunjiao Liu, Xiaofen Li, et al.
Cell Death & Disease|June 16, 2017
Bilirubin neurotoxicity is associated with proteasome inhibitionHongbiao Huang, Mingxing Guo, Ningning Liu, et al.
Scientific Reports|April 27, 2016
MYH9 is an Essential Factor for Porcine Reproductive and Respiratory Syndrome Virus InfectionJiming Gao, Shuqi Xiao, Yihong Xiao, et al.
Blood|January 22, 2025
CD44-mediated metabolic rewiring is a targetable dependency of IDH-mutant leukemiaJunhua Lyu, Yuxuan Liu, Ningning Liu, et al.
Frontiers in Bioscience (Elite Edition)|May 31, 2011
Sanggenon C decreases tumor cell viability associated with proteasome inhibitionHongbiao Huang, Ningning Liu, Kai Zhao, et al.
Science Bulletin|January 19, 2023
Anisotropic gapping of topological Weyl rings in the charge-density-wave superconductor In<sub>x</sub>TaSe<sub>2</sub>Yupeng Li, Yi Wu, Chenchao Xu, et al.
Oncotarget|July 1, 2014
Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growthNingning Liu, Xiaofen Li, Hongbiao Huang, et al.
Pageof 29